|
KMID : 1144220190250020069
|
|
Journal of Menopausal Medicine
2019 Volume.25 No. 2 p.69 ~ p.73
|
|
|
Effect of Isoflavones and Genistein on Glucose Metabolism in Peri- and Post-Menopausal Women: An Overview of Meta-Analysis
|
|
Maliehe Afiat
Ghahremani Sara
Kharghani Sara
Ghazanfarpour Masumeh
Shariati Khatereh
Kazemi Maryam
Khadivzadeh Talat
|
|
|
Abstract
|
|
|
|
The purpose of the present overview of meta-analysis is to summarize and critically assess the effect of isoflavones and genistein on glucose metabolism among the peri- and post-menopausal women. Two independent authors searched the databases of MEDLINE, Scopus and Cochrane Library for meta-analysis. Three databases were searched from inception to January 2018. Methodological quality of each meta-analysis of randomized controlled trials was evaluated using the AMSTAR (a measurement tool used to assess systematic reviews). Four meta-analyses were included to the current overview. Fasting insulin levels and homeostatic model assessment of insulin resistance (HOMA-IR) values were significantly lower in peri-menopausal and postmenopausal. Two meta-analyses showed that treatment with isoflavones could not alter fasting blood glucose. However, one meta-analysis depicted that isoflavones significantly improved blood glucose levels in non-Asian postmenopausal women. Treatment with genistein could have significant beneficial effects on fasting insulin, blood glucose and HOMA-IR in comparison to the control group. Regardless of the population, the treatment with genistein is effective in improving fasting insulin, HOMA-IR and glucose levels. Nevertheless, the high heterogeneity among studies and poor methodology of reviews made it difficult to draw a definite conclusion on the positive impacts of soy on glucose metabolism.
|
|
|
KEYWORD
|
|
|
Genistein, Glucose metabolism disorders, Insulins, Isoflavones, Menopause
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|